InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Moch Kenneth I, Director. Director active across 2 companies, notably Zynerba Pharmaceuticals, Inc.. In total, 8 reports have been published. Activity tracked since 3 August 2021. The latest transaction was filed on 31 January 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
MOCH KENNETH I is Administrateur and has 8 filings in total. The most recent filings we hold cover the period from 2021-08-05 to 2024-02-02, with transactions described as Attribution and buy and sell amounts of EUR 0 on this recent sample. He is linked to Gamida Cell Ltd. and Zynerba Pharmaceuticals, Inc.